- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Cooper Pharmaceuticals Inc C
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Cooper Pharmaceuticals Inc C will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Cooper Pharmaceuticals Inc C VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Cooper Pharmaceuticals Inc C VRIO Analysis shows that the financial resources of Cooper Pharmaceuticals Inc C are highly valuable as these help in investing into external opportunities that arise. These also help Cooper Pharmaceuticals Inc C in combating external threats.
- According to the VRIO Analysis of Cooper Pharmaceuticals Inc C, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Cooper Pharmaceuticals Inc C VRIO Analysis shows that Cooper Pharmaceuticals Inc C's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Cooper Pharmaceuticals Inc C's products.
- According to the VRIO Analysis of Cooper Pharmaceuticals Inc C, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Cooper Pharmaceuticals Inc C. These patents also provide Cooper Pharmaceuticals Inc C with licensing revenue when it licenses these patents out to other manufacturers.
- The Cooper Pharmaceuticals Inc C VRIO Analysis shows that Cooper Pharmaceuticals Inc C’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Cooper Pharmaceuticals Inc C. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Cooper Pharmaceuticals Inc C, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Cooper Pharmaceuticals Inc C VRIO Analysis shows that the research and development at Cooper Pharmaceuticals Inc C is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Cooper Pharmaceuticals Inc C. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Cooper Pharmaceuticals Inc C are found to be rare according to the VRIO Analysis of Cooper Pharmaceuticals Inc C. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Cooper Pharmaceuticals Inc C VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Cooper Pharmaceuticals Inc C and inhibit competitive advantage. This means that the local food products result in competitive parity for Cooper Pharmaceuticals Inc C. As this resource is valuable, Cooper Pharmaceuticals Inc C can still make use of this resource.
- The employees of Cooper Pharmaceuticals Inc C are a rare resource as identified by the VRIO Analysis of Cooper Pharmaceuticals Inc C. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Cooper Pharmaceuticals Inc C are a rare resource as identified by the Cooper Pharmaceuticals Inc C VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Cooper Pharmaceuticals Inc C to use them without interference from the competition.
- The distribution network of Cooper Pharmaceuticals Inc C is a rare resource as identified by the VRIO Analysis of Cooper Pharmaceuticals Inc C. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Cooper Pharmaceuticals Inc C. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Cooper Pharmaceuticals Inc C are costly to imitate as identified by the Cooper Pharmaceuticals Inc C VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Cooper Pharmaceuticals Inc C. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Cooper Pharmaceuticals Inc C provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Cooper Pharmaceuticals Inc C are also not costly to imitate as identified by the Cooper Pharmaceuticals Inc C VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Cooper Pharmaceuticals Inc C by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Cooper Pharmaceuticals Inc C a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Cooper Pharmaceuticals Inc C are very difficult to imitate as identified by the VRIO Analysis of Cooper Pharmaceuticals Inc C. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Cooper Pharmaceuticals Inc C is also very costly to imitate by competition as identified by the Cooper Pharmaceuticals Inc C VRIO Analysis. This has been developed over the years gradually by Cooper Pharmaceuticals Inc C. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Cooper Pharmaceuticals Inc C are organised to capture value as identified by the VRIO Analysis of Cooper Pharmaceuticals Inc C. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Cooper Pharmaceuticals Inc C.
- The Patents of Cooper Pharmaceuticals Inc C are not well organised as identified by the Cooper Pharmaceuticals Inc C VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Cooper Pharmaceuticals Inc C starts selling patented products before the patents expire.
- The distribution network of Cooper Pharmaceuticals Inc C is organised as identified by the VRIO Analysis of Cooper Pharmaceuticals Inc C. Cooper Pharmaceuticals Inc C uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Cooper Pharmaceuticals Inc C.
From the VRIO Analysis of Cooper Pharmaceuticals Inc C, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Cooper Pharmaceuticals Inc C is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Benjamin
5.0
The turnaround time and the quality of the paper were just awesome. Paper was totally composed according to my instruction. Thank you!
Mike Yang
4.0
I have stopped taking the stress of college assignments because this service solves any matter regarding the papers.
James Alexander
5.0
The charges were shallow and the quality of the content was fine. When I found this service, I thought that I should use it once and I hired it. Thankfully achieved the nice assignment. Thanks!
Caihong Song
5.0
Very professional service and this company went above and beyond to my expectations. Thank you!
Next Articles
- Snapple Beverage Corporation Vrio Analysis
- Roast, Grind, Brew, Kickstart Vrio Analysis
- NORAM FOODS Vrio Analysis
- NORANDA ANDACOLLO Vrio Analysis
- FINANCIAL ANALYSIS OF MARKETING DECISIONS Vrio Analysis
- LONDON REGIONAL CHILDREN'S MUSEUM Vrio Analysis
- ROSA'S PALAS FRANCHISE Vrio Analysis
- NOTE ON CASE ANALYSIS Vrio Analysis
- CANADAIR CHALLENGER JET Vrio Analysis
- PROTECT A PLATE VENTURE Vrio Analysis
Previous Articles
- Bombardier (B): The Los Angeles Metro Transit Authority Decision Vrio Analysis
- IBM And Apple Computer Alliance (D) Epilogue: 1995 96 Vrio Analysis
- IBM And Apple Computer Alliance (B) Vrio Analysis
- IBM And Apple Computer Alliance (C) Vrio Analysis
- IBM And Apple Computer Alliance (A) Vrio Analysis
- Cott Versus Coca Cola: The Private Label Challenge Vrio Analysis
- Pampers: The Disposable Diaper War (A) Vrio Analysis
- Telezoo (C) Vrio Analysis
- FedEx And UPS—The War Continues Vrio Analysis
- Fiat And Chrysler: Gaining On Global Automakers? Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!